申请人:Vitae Pharmaceuticals, Inc.
公开号:US10336717B2
公开(公告)日:2019-07-02
The present invention is directed to a compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
本发明涉及一种由以下结构式表示的化合物
或其药学上可接受的盐。此外,还介绍了这些化合物的药物组合物和使用方法。